Can you provide a list of the following medications with their dosing and indications: potassium chloride extended‑release 10 mEq capsule, tizanidine extended‑release 4 mg tablet, amlodipine 5 mg tablet, aripiprazole (Abilify Asimtufii) 960 mg/3.2 mL oral suspension, extended‑release intramuscular injection (unspecified), buspirone 15 mg tablet, hydrochlorothiazide 12.5 mg tablet, pantoprazole 40 mg delayed‑release tablet, loratadine 10 mg capsule, and glipizide 5 mg tablet?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Medication List with Dosing and Indications

1. Potassium Chloride ER 10 mEq Capsule

Indications: Treatment and prevention of hypokalemia (low potassium levels), particularly in patients on diuretics or with conditions causing potassium loss.

Dosing:

  • Typical dose: 10-20 mEq once or twice daily
  • Maximum: Generally up to 100 mEq/day in divided doses for severe depletion
  • The extended-release formulation allows for sustained absorption and reduces gastrointestinal irritation compared to immediate-release forms 1
  • Monitor serum potassium and renal function regularly, especially when combined with ACE inhibitors, ARBs, or potassium-sparing diuretics due to hyperkalemia risk 2

2. Tizanidine 4 mg Tablet

Indications: Muscle relaxant for spasticity associated with multiple sclerosis, spinal cord injury, or other neurological conditions.

Dosing:

  • Initial: 2 mg orally at night
  • Titration: Increase by 2-4 mg every few days as tolerated
  • Typical maintenance: 8 mg every 8 hours (24 mg/day total)
  • Maximum: Up to 36 mg/day in divided doses 3
  • Critical warning: Contraindicated with CYP1A2 inhibitors (e.g., oral contraceptives) and use caution with methadone due to QTc prolongation risk 3
  • Common side effects include sedation, hypotension, dry mouth, and hepatotoxicity—monitor liver function 3

3. Amlodipine 5 mg Tablet

Indications: Hypertension and chronic stable angina.

Dosing:

  • Initial: 2.5-5 mg once daily
  • Maximum: 10 mg once daily 4, 5
  • In heart failure with reduced ejection fraction (HFrEF): Amlodipine is safe and recommended when additional blood pressure control is needed beyond ACE inhibitors/ARBs, beta-blockers, and diuretics 6
  • In pediatrics (6-17 years): Start 2.5 mg daily, maximum 5 mg daily 4
  • Side effects include peripheral edema, headache, and flushing 5

4. Abilify Asimtufii 960 mg/3.2 mL Suspension, Extended-Release IM Syringe

Indications: Maintenance treatment of schizophrenia and bipolar I disorder in adults.

Dosing:

  • Administration: Intramuscular injection (gluteal) given once every 2 months after appropriate oral aripiprazole stabilization
  • Dose: 960 mg (3.2 mL) IM every 2 months 7
  • Critical considerations:
    • Requires oral aripiprazole overlap for 21 days after first injection
    • Adjust dose with strong CYP3A4 or CYP2D6 inhibitors/inducers 7
    • Black box warning: Increased mortality in elderly patients with dementia-related psychosis 7
  • Monitor for metabolic changes (weight gain, diabetes, dyslipidemia), tardive dyskinesia, neuroleptic malignant syndrome, and orthostatic hypotension 7

5. Buspirone 15 mg Tablet

Indications: Generalized anxiety disorder (GAD).

Dosing:

  • Initial: 7.5 mg twice daily (15 mg/day total)
  • Titration: Increase by 5 mg/day every 2-3 days as needed
  • Typical maintenance: 15-30 mg/day in divided doses (twice or three times daily)
  • Maximum: 60 mg/day
  • Takes 2-4 weeks for full anxiolytic effect
  • Does not cause dependence or withdrawal, unlike benzodiazepines
  • Side effects include dizziness, headache, and nausea

6. Hydrochlorothiazide 12.5 mg Tablet

Indications: Hypertension, edema associated with heart failure or renal disease.

Dosing:

  • Hypertension: 12.5-25 mg once daily
  • Maximum: 50 mg/day 4
  • In heart failure: Thiazides recommended as add-on therapy when blood pressure not controlled with ACE inhibitor/ARB, beta-blocker, and MRA 6
  • Critical monitoring: Check electrolytes (potassium, sodium, magnesium) and renal function shortly after initiation and periodically thereafter 4, 2
  • Avoid hypokalemia—consider potassium supplementation or potassium-sparing diuretic if needed 8, 2
  • Less effective when GFR <30 mL/min; switch to loop diuretic 2

7. Pantoprazole 40 mg Tablet, Delayed Release

Indications: Gastroesophageal reflux disease (GERD), erosive esophagitis, Zollinger-Ellison syndrome, prevention of NSAID-induced ulcers.

Dosing:

  • GERD/erosive esophagitis: 40 mg once daily for 8 weeks
  • Maintenance: 40 mg once daily
  • Zollinger-Ellison: 40 mg twice daily, titrate up to 240 mg/day if needed
  • Take 30 minutes before meals for optimal effect
  • Long-term use (>1 year) associated with increased risk of fractures, hypomagnesemia, vitamin B12 deficiency, and Clostridioides difficile infection—use lowest effective dose for shortest duration

8. Loratadine 10 mg Capsule

Indications: Allergic rhinitis (seasonal and perennial), chronic idiopathic urticaria.

Dosing:

  • Adults and children ≥6 years: 10 mg once daily
  • Children 2-5 years: 5 mg once daily
  • Renal/hepatic impairment: 10 mg every other day
  • Non-sedating second-generation antihistamine
  • Can be taken without regard to meals

9. Glipizide 5 mg Tablet

Indications: Type 2 diabetes mellitus as adjunct to diet and exercise.

Dosing:

  • Initial: 5 mg once daily before breakfast
  • Titration: Increase by 2.5-5 mg every few days based on blood glucose response
  • Typical maintenance: 5-10 mg once or twice daily
  • Maximum: 40 mg/day (doses >15 mg should be divided)
  • Extended-release formulation: 5-10 mg once daily, maximum 20 mg/day
  • Take immediate-release 30 minutes before meals
  • Critical warning: Risk of hypoglycemia, especially in elderly, malnourished, or those with renal/hepatic impairment
  • Monitor blood glucose regularly and adjust dose accordingly

References

Research

Pharmacokinetics and effects on fecal blood loss of a controlled release potassium chloride tablet.

The Journal of pharmacology and experimental therapeutics, 1978

Related Questions

For a patient with a serum potassium of 2.59 mmol/L, how many oral potassium‑chloride tablets are required to correct the deficit?
What is the appropriate next step in management for a 25‑year‑old female patient who has been taking levosulpiride 50 mg once daily, escitalopram (Mor­cet) 5 mg at night, propranolol 10 mg twice daily, and alprazolam 0.0625 mg three times daily for two weeks, with modest symptom improvement but now experiencing health‑related anxiety, fear of salt and sweets, and excessive rumination?
What is the safest muscle relaxant for a patient with lumbar strain, taking Sertraline (Selective Serotonin Reuptake Inhibitor) and Trazodone (Triazolopyridine)?
What is the recommended treatment for hypokalemia (low potassium levels) according to NHS (National Health Service) guidelines?
How many mmol/L will a single oral potassium chloride tablet increase serum potassium by?
What is the appropriate oral vitamin C dosage for treating bladder spasms?
Do serum immunofixation electrophoresis (SIFE) and quantitative immunoglobulin level testing both require a serum sample obtained by standard venipuncture?
Can snorting Miralax (polyethylene glycol 3350) cause a low white blood cell count?
What muscle relaxant medications are appropriate for treating bladder spasms?
What are the potential side effects of a glucagon-like peptide‑1 (GLP‑1) receptor agonist used for ophthalmic (eye) applications?
What role do caffeine and alcohol have on sleep quality and sleep architecture?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.